Anna Kettermann has 15 years of experience as a biostatistician working on interdisciplinary projects hand-in-glove with teams of physicians, medical officers, pharmacologists, and other scientists, reaching 10 years in FDA last year and 5 in CDER. Anna came to FDA following 5 years of ground-breaking research at Johns Hopkins University School of Medicine which yielded 16 peer-reviewed publications. Her career at FDA led to CDER, where she is leading the path forward in reviewing drug submissions. She serves on various interdisciplinary committees and working groups.